Dimension Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Dimension Therapeutics generated cash of -$47,644,000, which is less than the previous year. Cash used in financing activities reached the amount of $5,143,000 last year. Net change in cash is therefore -$96,813,000.
Cash Flow
| 2015 | -32.02M | -2.48M | 143.64M |
|---|---|---|---|
| 2016 | -47.64M | -54.31M | 5.14M |
DMTX Cash Flow Statement (2015 – 2016)
| 2016 | 2015 | |
|---|---|---|
Cash at beginning of period | 127.04M | 17.91M |
Operating activities | ||
Net income | -49.00M | -35.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 1.61M | 716K |
Stock-based compensation expense | 0 | 0 |
| Deferred income tax benefit | 0 | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -1.74M | 1.83M |
Inventories | -115.80M | 0 |
Accounts payable | 814K | 1.14M |
Cash generated by operating activities | -47.64M | -32.02M |
Investing activities | ||
Purchases Of Investments | -54.19M | 0 |
Investments In Property Plant And Equipment | -6.71M | -2.54M |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -54.31M | -2.48M |
Financing activities | ||
Common Stock Issued | 43K | 5K |
Payments for dividends | 0 | 0 |
Repurchases of common stock | -30.23M | -127.04M |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | 5.14M | 143.64M |
Net Change In Cash | -96.81M | 109.13M |
Cash at end of period | 30.23M | 127.04M |
| Data source | Data source |